In November 2021, which of the following countries has approved a COVID-19 antiviral pill Molnupiravir, jointly developed by United States-based Merck and Ridgeback Biotherapeutics?

In November 2021, which of the following countries has approved a COVID-19 antiviral pill Molnupiravir, jointly developed by United States-based Merck and Ridgeback Biotherapeutics? Correct Answer Britain

The correct answer is Britain.

Key Points

  • Britain has become the first country in the world to approve a COVID-19 antiviral pill jointly developed by United States-based Merck and Ridgeback Biotherapeutics.
  • Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.

Important Points

  • This is the first oral antiviral treatment for COVID-19 to get approved, with the green light coming ahead of potential United States regulatory clearance.
  • The drug, to be branded Lagevrio in Britain, is designed to introduce errors into the genetic code of the virus that causes COVID-19 and is taken twice a day for five days.

Additional Information

  • In November 2021, World Health Organisation has recommended the Emergency Use Listing status for Bharat Biotech’s Covaxin.
  • Covaxin is a whole virion-inactivated vaccine against SARS-CoV2, developed in partnership with ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology), Pune.

Related Questions

In April 2021, which of the following has successfully developed and filed a patent application(s) for novel biocatalytic technology of manufacturing Molnupiravir?
In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the following suggested courses of actions logically follow(s) for pursuing. Statement: Soon VAT 69 whiskey and Smirnoff Vodka will not be found on the shelves of Delhi Liquor stores owing to the duplication of barcode by manufacturer United Limited. The Delhi government financial commissioner blacklisted the manufacturer. Financial commissioner Anindo Majumdar had said in an order dated September 14, that USL had violated provisions of the Delhi Excise Act, 2009 and Delhi Excise Rules, 2010 by using unauthorized and loose barcodes, which could be easily misused. Courses of action: I. The ban will force United Spirits Limited not to sell its liquor in the national capital for two years. II. the appellant violated provisions of the Delhi Excise Act, 2009, Delhi Excise Rules, 2010, the terms and conditions of the license issued to it and the standard operating procedure framed by the Delhi Excise Department and that consequently the department has rightly imposed the penalty of blacklisting under Rule 70 of the Delhi Excise Rules, 2010 upon United Spirits LTD (USL), Aurangabad. III. United Limited has been blacklisted by the Delhi government financial commissioner.